BBA
ALT icon

Baker Bros. Advisors’s Altimmune ALT Stock Holding History

Baker Bros. Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-653,562
Closed -$10.8M – 106
2022
Q4 		$10.8M Sell
653,562
-1,116,119
-63% -$12.5M 0.06% 56
2022
Q3 		$22.6M Sell
1,769,681
-305,722
-15% -$4.51M 0.15% 43
2022
Q2 		$24.3M Buy
2,075,403
+1,003,365
+94% +$6.19M 0.14% 41
2022
Q1 		$6.53M Hold
1,072,038
– – 0.04% 80
2021
Q4 		$9.82M Hold
1,072,038
– – 0.05% 77
2021
Q3 		$12.1M Hold
1,072,038
– – 0.05% 73
2021
Q2 		$10.6M Sell
1,072,038
-1,686,480
-61% -$23.1M 0.05% 76
2021
Q1 		$39M Buy
2,758,518
+874,067
+46% +$14.1M 0.17% 48
2020
Q4 		$21.3M Sell
1,884,451
-322,504
-15% -$3.8M 0.08% 56
2020
Q3 		$29.1M Buy
2,206,955
+99,355
+5% +$1.99M 0.12% 43
2020
Q2 		$22.6M Buy
+2,107,600
New +$11.6M 0.1% 45

Other funds holding ALT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Baker Bros. Advisors's ALT Position: Q1 2023 in Review

Baker Bros. Advisors sold out of Altimmune (ALT) in Q1 2023, closing a stake of 653,562 shares — an estimated $10.8M sold.

Baker Bros. Advisors first reported a position in ALT in Q2 2020 and held it in 11 quarters. The position peaked at $39M in Q1 2021. 132 funds tracked by Wall St. Rank hold ALT as of Q1 2023.

  • Baker Bros. Advisors reported no remaining Altimmune position as of Q1 2023 after selling out during the quarter.
  • Baker Bros. Advisors sold 653,562 Altimmune shares in Q1 2023, an estimated $10.8M.
  • Baker Bros. Advisors first reported a position in Altimmune in Q2 2020 and held it in 11 quarters.
  • Baker Bros. Advisors's Altimmune position peaked at $39M in Q1 2021.
  • 132 funds tracked by Wall St. Rank held Altimmune as of Q1 2023.

Based on Baker Bros. Advisors's 13F filing for Q1 2023, filed 15 May 2023.